New Board Appointments Position BioCity for Growth

Share Article

BioCity Nottingham, one of Europe's largest and fastest growing bioscience business incubators, has strategically strengthened its Board of Directors in readiness for further significant development of the business.

Lucy P. Marcus and Stefan Ogrodzinski have been appointed to help drive forward BioCity's rapid continuing development and are already putting their energies into building BioCity's reputation and profile, taking the organisation to new levels of national and international influence.

BioCity Nottingham was launched in 2003 and the award winning site already provides a supportive environment for 60 developing biotechnology and healthcare companies employing over 500. The facility was made possible by a huge donation of laboratory and office buildings and specialist equipment from BASF to Nottingham Trent University in 2001, resulting in a state-of-the-art three-building bioscience business campus.

Lucy P. Marcus is the founder and CEO of Marcus Venture Consulting, which works with clients across the globe in venture capital and private equity funds, institutions and corporations to help them create robust funding businesses. She sits on a number of boards around the world, including as chair of the board of the Aspen Institute Energy and Environment Awards, the board treasurer of the British American Project, and non-executive director, board treasurer, and chair of the board finance committee of the International Step-by-Step Association (ISSA). She is also a popular speaker on global economic trends and best practices for investment, private equity, venture capital, and entrepreneurship. Lucy's international profile and relationships, together with a solid understanding of financial management, make her a major asset to BioCity's growth plans.

Lucy commented: "Nothing is more important than supporting early stage companies, and particularly during this challenging economic time. These companies are the engine of our future economic growth and BioCity is perfectly placed to help nurture them and bring them to a point where they can become major employers, long term innovators, and strong contributors to the region and to the UK."

Stefan Ogrodzinski is an experienced entrepreneur in the Life Sciences sector, and brings over 20 years of sales, marketing, management and directorship experience to the board. He is a founding director of four Midlands-based Life Science companies; BioStatus, BioSuspensions, nanoTherics and magneCell, and a past Chairman and founding director of Medilink East Midlands Ltd.

He said: "BioCity is a valuable resource for East Midlands SME's in the healthcare and life science sectors. That value extends beyond the fine infrastructure and related facilities to the wide-ranging expertise and experience contained in the many companies and individuals who make up the BioCity community. Whilst serving on the BioCity board, I will be committed to harnessing that "added" value and making it more widely available in programmes and initiatives. I am firmly committed to the ongoing success and development of the healthcare and life-science sectors in the East Midlands."

BioCity Nottingham creates and develops early stage bioscience and pharmaceutical companies and offers flexible laboratory and office leasing arrangements meaning a company's growth requirements can be easily accommodated. This provides the ideal solution for many types of ventures including new start ups; university spin-outs, established SMEs and corporate relocations and expansions.

BioCity's Chief Executive, Glenn Crocker, says: "We are delighted to welcome Lucy P. Marcus and Stefan Ogrodzinski to the Board. Their joint expertise is perfectly aligned to help BioCity and its businesses grow. BioCity has big plans for the coming years and Lucy and Stefan are just the right people to help us attain our goals. This is a very exciting time for BioCity and I know that both new Board members are as committed to its success as we all are."

BioCity media contact:
Louise Third, Integra Communications
T: 0115 912 4350
E: louise @ integracommunications.co.uk

Photos of both new BioCity Board members are available on request from contact above.

BioCity Nottingham Ltd develops and operates bioscience and healthcare related incubation and innovation facilities. The first facility was opened in Nottingham in September 2003 and Phase 3, in the form of grow-on space, opened in October 2008. The 129,000 sq ft award-winning facility is currently home to 60 fast-growing companies, including R&D and business support services.

BioCity was founded by Nottingham Trent University, the University of Nottingham and East Midlands Development Agency.

Other BioCity Board members are:
Barry Stickings CBE - Chairman (Former Chairman, BASF plc)
Michael Carr - Executive Director of Business Services, emda
Dr Glenn Crocker - CEO, BioCity Nottingham
Dr Roy P Eady - Former Research Director, Astra Zeneca
Professor Neil T Gorman - Vice Chancellor, Nottingham Trent University
Professor Saul J B Tendler - Head of School of Pharmacy, The University of Nottingham
Ian JS Webster - Independent Consultant, former Director of Property, Boots plc
Dr Ian Wilding - Founder, Pharmaceutical Profiles

http://www.biocity.co.uk

Lucy P. Marcus is the founder and CEO of Marcus Venture Consulting (http://www.marcusventures.com), which works with clients across the globe in venture capital and private equity funds, institutions and corporations to help them create robust funding businesses. Lucy is the Chair of The Global Task Force on Building Women Leaders and Founder and CEO of HighTech Women, and she serves as an independent non-executive director and treasurer on the board of the International Step-by-Step Association (ISSA) and as a non-executive director and board treasurer and fellow of the British-American Project. She is co-founder, judge and Chair of the board of the Aspen Institute Energy and Environment Awards; a member of the international advisory board of the Instituto de Empresa Business School in Madrid and a member of the Advisory Board of Latilla LLC. Lucy is also on the board of the Wellesley College Business Leadership Council. She has just completed two consecutive terms on the advisory board of the University of Cambridge's Judge Business School.

She has worked in a number of sectors from software and the internet to government and financial services. Prior to founding Marcus Venture Consulting, Lucy worked at several places including Infinity Financial Technologies, Price Waterhouse and at the US Treasury Department's Economic Policy Division.

Selected as a World Economic Forum Global Leader for Tomorrow, Lucy is also a fellow of the Aspen Institute Henry Crown Fellowship Program. Lucy has been listed as a "face to watch" in Management Today Magazine's list of Britain's 50 Most Powerful Women and in Business Age Magazine's "10 Women Changing the Direction of British Business". She is a well regarded speaker on global economic trends and best practices for investment, private equity, venture capital, and entrepreneurship.

A dual American and British citizen, Lucy holds a B.A. from Wellesley College (Wellesley, Massachusetts) and an M.Phil. from the University of Cambridge (Cambridge, England).

Stefan Ogrodzinski received his BSc (Hons) in Toxicology and Pharmacology from The School of Pharmacy, University of London, in 1987 and his MBA from De Montfort University in 1999. In 2000, Stefan founded Biostatus and since that time has led the company as its CEO.

Stefan is also a Director of Medilink East Midlands Limited, a Director of MagneCell Limited, a Director of BioSuspensions Limited, a Director of nanoTherics, a member of the third mission committee at the Cardiff Institute of Tissue Engineering and Repair (CITER), a member of the advisory panel for the Astra Zeneca Post Doctoral Training Centre at Nottingham University and Senior Partner at Ogrodzinski Consultants.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Miranda Knaggs
Visit website